chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Therapeutic response unexpected, Weight decreased
Clinical narrative: lost weight; He said his skin lesions that look like rheumatoid arthritis are improving, cognitive abilities are functioning and improving, increased by 50 points. 'I was doing things which normally I have never been able to do; This spontaneous case was reported by a consumer and describes the occurrence of WEIGHT DECREASED (lost weight) and THERAPEUTIC RESPONSE UNEXPECTED (He said his skin lesions that look like rheumatoid arthritis are improving, cognitive abilities are functioning and improving, increased by 50 points. 'I was doing things which normally I have never been able to do) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC) for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WEIGHT DECREASED (lost weight) and THERAPEUTIC RESPONSE UNEXPECTED (He said his skin lesions that look like rheumatoid arthritis are improving, cognitive abilities are functioning and improving, increased by 50 points. 'I was doing things which normally I have never been able to do). At the time of the report, WEIGHT DECREASED (lost weight) and THERAPEUTIC RESPONSE UNEXPECTED (He said his skin lesions that look like rheumatoid arthritis are improving, cognitive abilities are functioning and improving, increased by 50 points. 'I was doing things which normally I have never been able to do) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.   This case was linked to MOD-2021-060368, MOD-2021-060546 (Patient Link).
Age: 81.0
Sex: U
Vaccine: COVID19
Symptoms: Adverse reaction, Pruritus
Clinical narrative: itching all over my body; reactions that causes me problems; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching all over my body) and ADVERSE REACTION (reactions that causes me problems) in an 81-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 073M20A and 007B71A) for COVID-19 vaccination.     Concomitant products included METOPROLOL, CLOPIDOGREL and ATORVASTATIN for an unknown indication.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching all over my body) and ADVERSE REACTION (reactions that causes me problems). The patient was treated with METHYLPREDNISOLONE at a dose of 4 mg once a day. At the time of the report, PRURITUS (itching all over my body) and ADVERSE REACTION (reactions that causes me problems) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhoea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhoea) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     Concomitant products included NISOLDIPINE, OMEPRAZOLE, HYDROCHLOROTHIAZIDE and ALPRAZOLAM for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced DIARRHOEA (Diarrhoea). At the time of the report, DIARRHOEA (Diarrhoea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021:
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia
Clinical narrative: weakness; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Congestive heart failure. Concomitant products included FUROSEMIDE (FUROSIMIDE) for Congestive heart failure, CITALOPRAM HYDROBROMIDE (CELEXA [CITALOPRAM HYDROBROMIDE]) for Depression, METOPROLOL for Hypertension, VITAMIN D3 for Vitamin D3 deficiency, ATORVASTATIN CALCIUM (LIPITOR), NITROGLYCERIN, METHADONE, ACETAMINOPHEN, EZETIMIBE (ZETIA), POTASSIUM CHLORIDE (MICRO K), ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]), SALBUTAMOL SULFATE (PROAIR [SALBUTAMOL SULFATE]) and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced ASTHENIA (weakness). At the time of the report, ASTHENIA (weakness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included chlorodyne. Treatment information was not provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Headache, Migraine, Peripheral swelling
Clinical narrative: migraines; swollen arm; red arm; severe headache; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraines), PERIPHERAL SWELLING (swollen arm), ERYTHEMA (red arm) and HEADACHE (severe headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21) for COVID-19 immunisation.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On an unknown date, the patient experienced MIGRAINE (migraines), PERIPHERAL SWELLING (swollen arm), ERYTHEMA (red arm) and HEADACHE (severe headache). At the time of the report, MIGRAINE (migraines) outcome was unknown and PERIPHERAL SWELLING (swollen arm), ERYTHEMA (red arm) and HEADACHE (severe headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included paracetamol.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness
Clinical narrative: Mild chronic dizziness and atlas joint is very sore and painful; Mild chronic dizziness and atlas joint is very sore and painful; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Mild chronic dizziness and atlas joint is very sore and painful) and ARTHRALGIA (Mild chronic dizziness and atlas joint is very sore and painful) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced DIZZINESS (Mild chronic dizziness and atlas joint is very sore and painful) and ARTHRALGIA (Mild chronic dizziness and atlas joint is very sore and painful). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, DIZZINESS (Mild chronic dizziness and atlas joint is very sore and painful) and ARTHRALGIA (Mild chronic dizziness and atlas joint is very sore and painful) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Musculoskeletal stiffness, Myalgia, Pain in extremity
Clinical narrative: Pain in the arm; Stiff neck; Tingling of his right arm; Headache; Chills; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the arm), MUSCULOSKELETAL STIFFNESS (Stiff neck), PARAESTHESIA (Tingling of his right arm), HEADACHE (Headache) and CHILLS (Chills) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Colonoscopy (received an anesthesia) on 20-Mar-2021. Concomitant products included PROSVENT for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in the arm), MUSCULOSKELETAL STIFFNESS (Stiff neck), PARAESTHESIA (Tingling of his right arm), HEADACHE (Headache), CHILLS (Chills) and MYALGIA (Body ache). At the time of the report, PAIN IN EXTREMITY (Pain in the arm), MUSCULOSKELETAL STIFFNESS (Stiff neck), PARAESTHESIA (Tingling of his right arm), HEADACHE (Headache), CHILLS (Chills) and MYALGIA (Body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medication was reported.  Treatment information was not provided
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Pain in the arm; Stiff neck; Tingling of his right arm; Headache; Chills; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the arm), MUSCULOSKELETAL STIFFNESS (Stiff neck), PARAESTHESIA (Tingling of his right arm), HEADACHE (Headache) and CHILLS (Chills) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Colonoscopy (received an anesthesia) on 20-Mar-2021. Concomitant products included PROSVENT for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in the arm), MUSCULOSKELETAL STIFFNESS (Stiff neck), PARAESTHESIA (Tingling of his right arm), HEADACHE (Headache), CHILLS (Chills) and MYALGIA (Body ache). At the time of the report, PAIN IN EXTREMITY (Pain in the arm), MUSCULOSKELETAL STIFFNESS (Stiff neck), PARAESTHESIA (Tingling of his right arm), HEADACHE (Headache), CHILLS (Chills) and MYALGIA (Body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medication was reported.  Treatment information was not provided
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Illness, Nausea
Clinical narrative: dizzy; feels very sick; tired; chills; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), ILLNESS (feels very sick), FATIGUE (tired), CHILLS (chills) and NAUSEA (nausea) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cholangitis (immunocompromised because of cholangitis).    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced DIZZINESS (dizzy), ILLNESS (feels very sick), FATIGUE (tired), CHILLS (chills) and NAUSEA (nausea). At the time of the report, DIZZINESS (dizzy), ILLNESS (feels very sick), FATIGUE (tired), CHILLS (chills) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-060561, MOD-2021-060561 (Patient Link).
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: Redness at injection site; Swelling at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE SWELLING (Swelling at injection site) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 03H821A and 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE SWELLING (Swelling at injection site). The patient was treated with LORATADINE (CLARITIN [LORATADINE]) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE ERYTHEMA (Redness at injection site) and VACCINATION SITE SWELLING (Swelling at injection site) outcome was unknown.            The patient was taking concomitant medication but did not specify the name. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Urinary tract infection
Clinical narrative: Too sick to get her shot; Urinary Tract Infection; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Too sick to get her shot) and URINARY TRACT INFECTION (Urinary Tract Infection) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     Concurrent medical conditions included Colitis aggravated and Psychiatric disorder NOS.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Too sick to get her shot) and URINARY TRACT INFECTION (Urinary Tract Infection). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Too sick to get her shot) had resolved and URINARY TRACT INFECTION (Urinary Tract Infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications included, 11 other medications for Psychiatric and severe colitis were reported.   Treatment information included, antibiotics was reported.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Limb discomfort, Pain in extremity, Pruritus, Vaccination site mass
Clinical narrative: spreading; bumpy around the injection site; spread to the other arm; red; itching like crazy; arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore), ERYTHEMA (red), PRURITUS (itching like crazy), PRURITUS (spreading) and VACCINATION SITE MASS (bumpy around the injection site) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LABETALOL, TOPIRAMATE, PARACETAMOL (TYLENOL) and IBUPROFEN (MOTRIN [IBUPROFEN]) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm was sore). On 21-Mar-2021, the patient experienced ERYTHEMA (red) and PRURITUS (itching like crazy). On 28-Mar-2021, the patient experienced PRURITUS (spreading), VACCINATION SITE MASS (bumpy around the injection site) and LIMB DISCOMFORT (spread to the other arm). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (arm was sore), ERYTHEMA (red), PRURITUS (itching like crazy), PRURITUS (spreading), VACCINATION SITE MASS (bumpy around the injection site) and LIMB DISCOMFORT (spread to the other arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other relevant concomitant medications included, Women's Vitamin One a day was reported.  Patient was applying cool wash cloth to the infected arms.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: itchy; red; tender; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PAIN (tender) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PAIN (tender). At the time of the report, VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PAIN (tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Diarrhoea, Nasopharyngitis, Vomiting
Clinical narrative: She could barely eat on Sunday; Early morning on Sunday, she woke up 6 to 7 times and had severe diarrhea/ She had diarrhea again on Sunday night to Monday morning; Early morning on Sunday, she woke up 6 to 7 times and had vomiting; Patient started with cold and chills next day morning; Patient started with cold and chills next day morning; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Patient started with cold and chills next day morning), DECREASED APPETITE (She could barely eat on Sunday), DIARRHOEA (Early morning on Sunday, she woke up 6 to 7 times and had severe diarrhea/ She had diarrhea again on Sunday night to Monday morning), CHILLS (Patient started with cold and chills next day morning) and VOMITING (Early morning on Sunday, she woke up 6 to 7 times and had vomiting) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and LORATADINE (CLARITIN [LORATADINE]) for an unknown indication.   On 26-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 ml. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced NASOPHARYNGITIS (Patient started with cold and chills next day morning) and CHILLS (Patient started with cold and chills next day morning). On 28-Mar-2021, the patient experienced DECREASED APPETITE (She could barely eat on Sunday), DIARRHOEA (Early morning on Sunday, she woke up 6 to 7 times and had severe diarrhea/ She had diarrhea again on Sunday night to Monday morning) and VOMITING (Early morning on Sunday, she woke up 6 to 7 times and had vomiting). At the time of the report, NASOPHARYNGITIS (Patient started with cold and chills next day morning), DECREASED APPETITE (She could barely eat on Sunday), DIARRHOEA (Early morning on Sunday, she woke up 6 to 7 times and had severe diarrhea/ She had diarrhea again on Sunday night to Monday morning), CHILLS (Patient started with cold and chills next day morning) and VOMITING (Early morning on Sunday, she woke up 6 to 7 times and had vomiting) outcome was unknown.            Relevant concomitant medications also included statin. No treatment information was provided(none).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003B21A and 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) (oral) for Fever, at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.  Patient was taking concomitant medications, which were not specified by the reporter.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Erythema, Pruritus
Clinical narrative: A day to 2 days later, she started with itching and red underneath breast area on both side.; A day to 2 days later, she started with itching and red underneath breast area on both side.; she had joint pain all over her body on next day; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (A day to 2 days later, she started with itching and red underneath breast area on both side.), ERYTHEMA (A day to 2 days later, she started with itching and red underneath breast area on both side.) and ARTHRALGIA (she had joint pain all over her body on next day) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE, LISINOPRIL, NAPROXEN and HYDROCODONE for an unknown indication.   On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 ml. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced PRURITUS (A day to 2 days later, she started with itching and red underneath breast area on both side.), ERYTHEMA (A day to 2 days later, she started with itching and red underneath breast area on both side.) and ARTHRALGIA (she had joint pain all over her body on next day). At the time of the report, PRURITUS (A day to 2 days later, she started with itching and red underneath breast area on both side.) and ERYTHEMA (A day to 2 days later, she started with itching and red underneath breast area on both side.) had not resolved and ARTHRALGIA (she had joint pain all over her body on next day) outcome was unknown.            No treatment information was reported.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Malaise
Clinical narrative: Diarrhea; Stomach issues; Wasn't feeling well; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), ABDOMINAL PAIN UPPER (Stomach issues) and MALAISE (Wasn't feeling well) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea), ABDOMINAL PAIN UPPER (Stomach issues) and MALAISE (Wasn't feeling well). At the time of the report, DIARRHOEA (Diarrhea), ABDOMINAL PAIN UPPER (Stomach issues) and MALAISE (Wasn't feeling well) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Lymphadenopathy, Migraine, Movement disorder, Myalgia
Clinical narrative: Knots under arm pits that makes it hard to move arm; Knots under arm pits that makes it hard to move arm; Migraine; Body aches; Fever; Sore arm; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MOVEMENT DISORDER (Knots under arm pits that makes it hard to move arm), MIGRAINE (Migraine), MYALGIA (Body aches), PYREXIA (Fever) and VACCINATION SITE PAIN (Sore arm) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B212A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced MIGRAINE (Migraine), MYALGIA (Body aches), PYREXIA (Fever), VACCINATION SITE PAIN (Sore arm) and CHILLS (Chills). On 27-Mar-2021, the patient experienced MOVEMENT DISORDER (Knots under arm pits that makes it hard to move arm) and LYMPHADENOPATHY (Knots under arm pits that makes it hard to move arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. On 28-Mar-2021, MIGRAINE (Migraine), MYALGIA (Body aches), PYREXIA (Fever) and CHILLS (Chills) had resolved, VACCINATION SITE PAIN (Sore arm) outcome was unknown. At the time of the report, MOVEMENT DISORDER (Knots under arm pits that makes it hard to move arm) and LYMPHADENOPATHY (Knots under arm pits that makes it hard to move arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Knots under arm pits that makes it hard to move arm; Knots under arm pits that makes it hard to move arm; Migraine; Body aches; Fever; Sore arm; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MOVEMENT DISORDER (Knots under arm pits that makes it hard to move arm), MIGRAINE (Migraine), MYALGIA (Body aches), PYREXIA (Fever) and VACCINATION SITE PAIN (Sore arm) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B212A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced MIGRAINE (Migraine), MYALGIA (Body aches), PYREXIA (Fever), VACCINATION SITE PAIN (Sore arm) and CHILLS (Chills). On 27-Mar-2021, the patient experienced MOVEMENT DISORDER (Knots under arm pits that makes it hard to move arm) and LYMPHADENOPATHY (Knots under arm pits that makes it hard to move arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. On 28-Mar-2021, MIGRAINE (Migraine), MYALGIA (Body aches), PYREXIA (Fever) and CHILLS (Chills) had resolved, VACCINATION SITE PAIN (Sore arm) outcome was unknown. At the time of the report, MOVEMENT DISORDER (Knots under arm pits that makes it hard to move arm) and LYMPHADENOPATHY (Knots under arm pits that makes it hard to move arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling, Insomnia, Nausea, Vaccination site pain
Clinical narrative: small redness at the injection site; small swelling at the injection site; nausea; pains in the arm that woke him up and prevented him from sleeping; pains in the arm that woke him up and prevented him from sleeping; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pains in the arm that woke him up and prevented him from sleeping), INSOMNIA (pains in the arm that woke him up and prevented him from sleeping), INJECTION SITE ERYTHEMA (small redness at the injection site), INJECTION SITE SWELLING (small swelling at the injection site) and NAUSEA (nausea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   Concomitant medications were not reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.   On 25-Mar-2021, the patient experienced VACCINATION SITE PAIN (pains in the arm that woke him up and prevented him from sleeping) and NAUSEA (nausea). On an unknown date, the patient experienced INSOMNIA (pains in the arm that woke him up and prevented him from sleeping), INJECTION SITE ERYTHEMA (small redness at the injection site) and INJECTION SITE SWELLING (small swelling at the injection site).   At the time of the report, VACCINATION SITE PAIN (pains in the arm that woke him up and prevented him from sleeping) and NAUSEA (nausea) outcome was unknown.      No treatment medications are included.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Musculoskeletal stiffness
Clinical narrative: face was becoming stiff; arm bothered a bit; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LIMB DISCOMFORT (arm bothered a bit) and MUSCULOSKELETAL STIFFNESS (face was becoming stiff) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DEXTRIN (BENEFIBER [DEXTRIN]) for an unknown indication.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced LIMB DISCOMFORT (arm bothered a bit). On 28-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (face was becoming stiff). At the time of the report, LIMB DISCOMFORT (arm bothered a bit) and MUSCULOSKELETAL STIFFNESS (face was becoming stiff) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Hypersensitivity, Influenza like illness, Nausea
Clinical narrative: sensitive to eggs; flu like symptoms; diarrhea; stomach cramps; nausea; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (sensitive to eggs), INFLUENZA LIKE ILLNESS (flu like symptoms), DIARRHOEA (diarrhea), ABDOMINAL PAIN UPPER (stomach cramps) and NAUSEA (nausea) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (sensitive to eggs), INFLUENZA LIKE ILLNESS (flu like symptoms), DIARRHOEA (diarrhea), ABDOMINAL PAIN UPPER (stomach cramps) and NAUSEA (nausea). At the time of the report, HYPERSENSITIVITY (sensitive to eggs), INFLUENZA LIKE ILLNESS (flu like symptoms), DIARRHOEA (diarrhea) and NAUSEA (nausea) outcome was unknown and ABDOMINAL PAIN UPPER (stomach cramps) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: bladder problems resolved; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (bladder problems resolved) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included Bladder discomfort.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (bladder problems resolved). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (bladder problems resolved) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   After couple of weeks of vaccination, Patient noticed that her bladder problems had resolved. Patient had overactive bladder, and she can now sleep through the night without urinating frequently.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Reporter's Email address and Street address has been added.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (rash). At the time of the report, RASH (rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. Treatment medications were not reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-060408 (E2B Linked Report). This case was linked to MOD-2021-060408 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-060408:Dose 1
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Injection site Itchy; Injection site Red; Injection site swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Injection site Itchy), VACCINATION SITE ERYTHEMA (Injection site Red) and VACCINATION SITE SWELLING (Injection site swollen) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site Itchy), VACCINATION SITE ERYTHEMA (Injection site Red) and VACCINATION SITE SWELLING (Injection site swollen). At the time of the report, VACCINATION SITE PRURITUS (Injection site Itchy), VACCINATION SITE ERYTHEMA (Injection site Red) and VACCINATION SITE SWELLING (Injection site swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was taking concomitant medications which were not specified.  Treatment information was not provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Dry skin, Rash, Rash pruritic, Tinnitus
Clinical narrative: Darker and the skin under my arm feels rather rough; rash on neck; 2 or 3 itchy bumps on elbow; Tinnitus increased to 3 times; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (2 or 3 itchy bumps on elbow), TINNITUS (Tinnitus increased to 3 times), DRY SKIN (Darker and the skin under my arm feels rather rough) and RASH (rash on neck) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced RASH PRURITIC (2 or 3 itchy bumps on elbow), TINNITUS (Tinnitus increased to 3 times) and RASH (rash on neck). On 14-Jul-2021, the patient experienced DRY SKIN (Darker and the skin under my arm feels rather rough). At the time of the report, RASH PRURITIC (2 or 3 itchy bumps on elbow), TINNITUS (Tinnitus increased to 3 times) and RASH (rash on neck) outcome was unknown and DRY SKIN (Darker and the skin under my arm feels rather rough) had not resolved.            The patient reported that 12 to 16 hours after the 2nd dose of vaccine she developed rash again, 2 or 3 bumps on the elbow and on the neck she noticed a skin rash which was very fine wrinkle lines.  The patient reported that she had tinnitus which got increased to 3 times after receiving vaccine. The rash was 3 times bigger with the 2nd dose as compared to  the 1st dose.  The patient developed the same odd rash under the right armpit.  No concomitant information was reported. No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-060405 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: NNI received On 16-Jul-2021: Non significant email follow up received On 19-Jul-2021: Significant FU Appended (event Info updated)
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling
Clinical narrative: Lip swelling near filler site that lasted 3 days.; This spontaneous case was reported by a non-health professional and describes the occurrence of LIP SWELLING (Lip swelling near filler site that lasted 3 days.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 23-Mar-2021, the patient experienced LIP SWELLING (Lip swelling near filler site that lasted 3 days.). At the time of the report, LIP SWELLING (Lip swelling near filler site that lasted 3 days.) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Vaccination site pruritus, Vein discolouration
Clinical narrative: Itching at the injection site; hard sharp, stabbing pain in lower part of right head; Headache; Tiredness; vein discoloration; This spontaneous case was reported by a consumer and describes the occurrence of VEIN DISCOLOURATION (vein discoloration), VACCINATION SITE PRURITUS (Itching at the injection site), HEADACHE (hard sharp, stabbing pain in lower part of right head), HEADACHE (Headache) and FATIGUE (Tiredness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included RIVAROXABAN (XARELTO), BUDESONIDE (PULMICORT), TRAMADOL, GABAPENTIN (NEURONTIN) and ALPRAZOLAM (XANAX) for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced VEIN DISCOLOURATION (vein discoloration), HEADACHE (Headache) and FATIGUE (Tiredness). On 28-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site) and HEADACHE (hard sharp, stabbing pain in lower part of right head). On 22-Mar-2021, VEIN DISCOLOURATION (vein discoloration), HEADACHE (Headache) and FATIGUE (Tiredness) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Itching at the injection site) and HEADACHE (hard sharp, stabbing pain in lower part of right head) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included, antihistamines was provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Nausea, Pain in extremity
Clinical narrative: itchy rash,pink; mildly sore arm; my legs/arms and face are itchy; Fever; headache; aches; fatigue; nausea; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (itchy rash,pink), PAIN IN EXTREMITY (mildly sore arm), PRURITUS (my legs/arms and face are itchy), PYREXIA (Fever) and HEADACHE (headache) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (itchy rash,pink), PAIN IN EXTREMITY (mildly sore arm), PRURITUS (my legs/arms and face are itchy), PYREXIA (Fever), HEADACHE (headache), MYALGIA (aches), FATIGUE (fatigue) and NAUSEA (nausea). At the time of the report, RASH PRURITIC (itchy rash,pink), PAIN IN EXTREMITY (mildly sore arm), PRURITUS (my legs/arms and face are itchy), PYREXIA (Fever), HEADACHE (headache), MYALGIA (aches), FATIGUE (fatigue) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment information not provided. Concomitant medications were not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-060418 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-060418:dose 2 (crosslink)
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia, Rash pruritic
Clinical narrative: itchy rash,pink; mildly sore arm; my legs/arms and face are itchy; Fever; headache; aches; fatigue; nausea; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (itchy rash,pink), PAIN IN EXTREMITY (mildly sore arm), PRURITUS (my legs/arms and face are itchy), PYREXIA (Fever) and HEADACHE (headache) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH PRURITIC (itchy rash,pink), PAIN IN EXTREMITY (mildly sore arm), PRURITUS (my legs/arms and face are itchy), PYREXIA (Fever), HEADACHE (headache), MYALGIA (aches), FATIGUE (fatigue) and NAUSEA (nausea). At the time of the report, RASH PRURITIC (itchy rash,pink), PAIN IN EXTREMITY (mildly sore arm), PRURITUS (my legs/arms and face are itchy), PYREXIA (Fever), HEADACHE (headache), MYALGIA (aches), FATIGUE (fatigue) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment information not provided. Concomitant medications were not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-060418 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-060418:dose 2 (crosslink)
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Dyspnoea, Headache, Pyrexia
Clinical narrative: chills; fever; dizziness; splitting headache; lung symptoms; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHILLS (chills), PYREXIA (fever), DIZZINESS (dizziness), HEADACHE (splitting headache) and DYSPNOEA (lung symptoms) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced CHILLS (chills), PYREXIA (fever), DIZZINESS (dizziness), HEADACHE (splitting headache) and DYSPNOEA (lung symptoms). At the time of the report, CHILLS (chills), PYREXIA (fever), DIZZINESS (dizziness), HEADACHE (splitting headache) and DYSPNOEA (lung symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Relevant concomitant product usage were not reported by the reporter. No treatment details were added.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Influenza like illness, Nausea
Clinical narrative: Nausea; Stomach upset; Symptoms of flu; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Stomach upset), INFLUENZA LIKE ILLNESS (Symptoms of flu) and NAUSEA (Nausea) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (Stomach upset) and INFLUENZA LIKE ILLNESS (Symptoms of flu). On an unknown date, the patient experienced NAUSEA (Nausea). At the time of the report, ABDOMINAL DISCOMFORT (Stomach upset), INFLUENZA LIKE ILLNESS (Symptoms of flu) and NAUSEA (Nausea) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment medication was reported.   This case was linked to MOD-2021-125543 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: The new event influenza like illness was added. The onset date of abdominal discomfort and influenza like illness added and the outcome of the events updated as recovering.